Back to Search
Start Over
Eruptive basal cell carcinoma and lenalidomide: rising awareness among dermatologists.
- Source :
-
Dermatology Reports . 2023, Vol. 15 Issue 1, p1-2. 2p. - Publication Year :
- 2023
-
Abstract
- Because of its higher level of safety compared to its parent medicine, thalidomide, lenalidomide (L) is chosen for the treatment of multiple myeloma. We report a patient who, within a month of using L, developed more than 10 basal cell carcinomas. [ABSTRACT FROM AUTHOR]
- Subjects :
- *BASAL cell carcinoma
*LENALIDOMIDE
*DERMATOLOGISTS
*MULTIPLE myeloma
*THALIDOMIDE
Subjects
Details
- Language :
- English
- ISSN :
- 20367406
- Volume :
- 15
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Dermatology Reports
- Publication Type :
- Academic Journal
- Accession number :
- 162443849
- Full Text :
- https://doi.org/10.4081/dr.2022.9534